- Home
- Publications
- Publication Search
- Publication Details
Title
The molecular pathogenesis of the myelodysplastic syndromes
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF HAEMATOLOGY
Volume 95, Issue 1, Pages 3-15
Publisher
Wiley
Online
2015-01-21
DOI
10.1111/ejh.12515
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes
- (2015) Moritz Gerstung et al. Nature Communications
- Myelodysplastic syndromes: 2014 update on diagnosis, risk-stratification, and management
- (2014) Guillermo Garcia-Manero AMERICAN JOURNAL OF HEMATOLOGY
- TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients
- (2014) R. Bejar et al. BLOOD
- Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia
- (2014) L. Malcovati et al. BLOOD
- Depletion of Sf3b1 impairs proliferative capacity of hematopoietic stem cells but is not sufficient to induce myelodysplasia
- (2014) C. Wang et al. BLOOD
- Genetic alterations of the cohesin complex genes in myeloid malignancies
- (2014) S. Thota et al. BLOOD
- Role of Casein Kinase 1A1 in the Biology and Targeted Therapy of del(5q) MDS
- (2014) Rebekka K. Schneider et al. CANCER CELL
- Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo
- (2014) Petter S. Woll et al. CANCER CELL
- Functional genomics identifies a requirement of pre-mRNA splicing factors for sister chromatid cohesion
- (2014) S. Sundaramoorthy et al. EMBO JOURNAL
- SNW1 enables sister chromatid cohesion by mediating the splicing of sororin and APC2 pre-mRNAs
- (2014) P. van der Lelij et al. EMBO JOURNAL
- Somatic Mutations Predict Poor Outcome in Patients With Myelodysplastic Syndrome After Hematopoietic Stem-Cell Transplantation
- (2014) Rafael Bejar et al. JOURNAL OF CLINICAL ONCOLOGY
- Distinct iron architecture in SF3B1-mutant myelodysplastic syndrome patients is linked to an SLC25A37 splice variant with a retained intron
- (2014) V Visconte et al. LEUKEMIA
- Haploinsufficiency of Sf3b1 leads to compromised stem cell function but not to myelodysplasia
- (2014) M Matsunawa et al. LEUKEMIA
- PRPF8 defects cause missplicing in myeloid malignancies
- (2014) A Kurtovic-Kozaric et al. LEUKEMIA
- Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine
- (2014) Cecile Bally et al. LEUKEMIA RESEARCH
- Identification of a BRCA1-mRNA Splicing Complex Required for Efficient DNA Repair and Maintenance of Genomic Stability
- (2014) Kienan I. Savage et al. MOLECULAR CELL
- Age-related mutations associated with clonal hematopoietic expansion and malignancies
- (2014) Mingchao Xie et al. NATURE MEDICINE
- Prognostic Value of Isocitrate Dehydrogenase Mutations in Myelodysplastic Syndromes: A Retrospective Cohort Study and Meta-Analysis
- (2014) Jie Jin et al. PLoS One
- Clinical implications of theSETBP1mutation in patients with primary myelodysplastic syndrome and its stability during disease progression
- (2013) Hsin-An Hou et al. AMERICAN JOURNAL OF HEMATOLOGY
- Prognostic impact ofRASmutations in patients with myelodysplastic syndrome
- (2013) Aref Al-Kali et al. AMERICAN JOURNAL OF HEMATOLOGY
- Mutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implications
- (2013) F. Thol et al. BLOOD
- CUX1 in leukemia: dosage matters
- (2013) J. Boultwood BLOOD
- Clinical and biological implications of driver mutations in myelodysplastic syndromes
- (2013) E. Papaemmanuil et al. BLOOD
- Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34+progenitor cells
- (2013) Carwyn Davies et al. BRITISH JOURNAL OF HAEMATOLOGY
- TP53mutations in myelodysplastic syndrome are strongly correlated with aberrations of chromosome 5, and correlate with adverse prognosis
- (2013) Austin G. Kulasekararaj et al. BRITISH JOURNAL OF HAEMATOLOGY
- Spliceosome mutations exhibit specific associations with epigenetic modifiers and proto-oncogenes mutated in myelodysplastic syndrome
- (2013) S. A. Mian et al. HAEMATOLOGICA
- Identification of Gene Expression–Based Prognostic Markers in the Hematopoietic Stem Cells of Patients With Myelodysplastic Syndromes
- (2013) Andrea Pellagatti et al. JOURNAL OF CLINICAL ONCOLOGY
- Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo
- (2013) Omar Abdel-Wahab et al. JOURNAL OF EXPERIMENTAL MEDICINE
- SETBP1 mutation analysis in 944 patients with MDS and AML
- (2013) F Thol et al. LEUKEMIA
- SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias
- (2013) F Damm et al. LEUKEMIA
- Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
- (2013) T Haferlach et al. LEUKEMIA
- Somatic SETBP1 mutations in myeloid malignancies
- (2013) Hideki Makishima et al. NATURE GENETICS
- Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms
- (2013) Ayana Kon et al. NATURE GENETICS
- A conformational switch in PRP8 mediates metal ion coordination that promotes pre-mRNA exon ligation
- (2013) Matthew J Schellenberg et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- FLT3mutations in myelodysplastic syndrome and chronic myelomonocytic leukemia
- (2012) Naval Daver et al. AMERICAN JOURNAL OF HEMATOLOGY
- Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes
- (2012) F. Damm et al. BLOOD
- Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes
- (2012) F. Thol et al. BLOOD
- SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes
- (2012) V. Visconte et al. BLOOD
- The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution
- (2012) S.-J. Wu et al. BLOOD
- Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis
- (2012) H. Makishima et al. BLOOD
- CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia
- (2012) M. E. McNerney et al. BLOOD
- Revised International Prognostic Scoring System for Myelodysplastic Syndromes
- (2012) P. L. Greenberg et al. BLOOD
- Defects in spliceosomal machinery: a new pathway of leukaemogenesis
- (2012) Jaroslaw P. Maciejewski et al. BRITISH JOURNAL OF HAEMATOLOGY
- ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression
- (2012) Omar Abdel-Wahab et al. CANCER CELL
- Mutations in epigenetic regulators in myelodysplastic syndromes
- (2012) Gorica Nikoloski et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes
- (2012) Rafael Bejar et al. JOURNAL OF CLINICAL ONCOLOGY
- New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge
- (2012) Julie Schanz et al. JOURNAL OF CLINICAL ONCOLOGY
- Recurrent SETBP1 mutations in atypical chronic myeloid leukemia
- (2012) Rocco Piazza et al. NATURE GENETICS
- Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis
- (2012) Lambert Busque et al. NATURE GENETICS
- Clonal Architecture of Secondary Acute Myeloid Leukemia
- (2012) Matthew J. Walter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lenalidomide promotes p53 degradation by inhibiting MDM2 auto-ubiquitination in myelodysplastic syndrome with chromosome 5q deletion
- (2012) S Wei et al. ONCOGENE
- Clinical Results With the DNA Hypomethylating Agent 5-Aza-2′-Deoxycytidine (Decitabine) in Patients With Myelodysplastic Syndromes: An Update
- (2012) Tina E. Joeckel et al. SEMINARS IN HEMATOLOGY
- Dnmt3a Protects Active Chromosome Domains against Cancer-Associated Hypomethylation
- (2012) Günter Raddatz et al. PLoS Genetics
- SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value
- (2011) M. M. Patnaik et al. BLOOD
- Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
- (2011) L. Malcovati et al. BLOOD
- Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies
- (2011) Z. Li et al. BLOOD
- Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q- syndrome
- (2011) M. S. Kumar et al. BLOOD
- The Spliceosome as an Indicted Conspirator in Myeloid Malignancies
- (2011) Omar Abdel-Wahab et al. CANCER CELL
- Overexpression of SET is a recurrent event associated with poor outcome and contributes to protein phosphatase 2A inhibition in acute myeloid leukemia
- (2011) I. Cristobal et al. HAEMATOLOGICA
- Cytogenetic abnormalities in myelodysplastic syndrome: an overview
- (2011) Nikesh Kawankar et al. Hematology
- TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression
- (2011) Martin Jädersten et al. JOURNAL OF CLINICAL ONCOLOGY
- Recurrent DNMT3A mutations in patients with myelodysplastic syndromes
- (2011) M J Walter et al. LEUKEMIA
- Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias
- (2011) R Itzykson et al. LEUKEMIA
- Frequent pathway mutations of splicing machinery in myelodysplasia
- (2011) Kenichi Yoshida et al. NATURE
- Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes
- (2011) Timothy A Graubert et al. NATURE GENETICS
- SomaticSF3B1Mutation in Myelodysplasia with Ring Sideroblasts
- (2011) E. Papaemmanuil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Effect of Point Mutations in Myelodysplastic Syndromes
- (2011) Rafael Bejar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetics of Myelodysplastic Syndromes: New Insights
- (2011) T. Graubert et al. Hematology-American Society of Hematology Education Program
- The Apcmin mouse has altered hematopoietic stem cell function and provides a model for MPD/MDS
- (2010) S. W. Lane et al. BLOOD
- Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value
- (2010) A. E. Smith et al. BLOOD
- Advances in the 5q- syndrome
- (2010) J. Boultwood et al. BLOOD
- Ribosomopathies: human disorders of ribosome dysfunction
- (2010) A. Narla et al. BLOOD
- ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia
- (2010) Véronique Gelsi-Boyer et al. BRITISH JOURNAL OF HAEMATOLOGY
- Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
- (2010) Maria E. Figueroa et al. CANCER CELL
- IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis
- (2010) F. Thol et al. HAEMATOLOGICA
- Epigenetic Changes in the Myelodysplastic Syndrome
- (2010) Jean-Pierre Issa HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Subclassification of Leukemia: Report From the International Microarray Innovations in Leukemia Study Group
- (2010) Torsten Haferlach et al. JOURNAL OF CLINICAL ONCOLOGY
- Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia
- (2010) J Boultwood et al. LEUKEMIA
- Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms
- (2010) O Kosmider et al. LEUKEMIA
- Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells
- (2010) A Pellagatti et al. LEUKEMIA
- Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
- (2010) Myunggon Ko et al. NATURE
- Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes
- (2010) Gorica Nikoloski et al. NATURE GENETICS
- Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
- (2010) Thomas Ernst et al. NATURE GENETICS
- Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis
- (2009) L. Malcovati et al. BLOOD
- Relationship of differential gene expression profiles in CD34+ myelodysplastic syndrome marrow cells to disease subtype and progression
- (2009) K. Sridhar et al. BLOOD
- Microarray-based classifiers and prognosis models identify subgroups with distinct clinical outcomes and high risk of AML transformation of myelodysplastic syndrome
- (2009) K. I. Mills et al. BLOOD
- TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)
- (2009) O. Kosmider et al. BLOOD
- Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms
- (2009) A. M. Jankowska et al. BLOOD
- Mutations of polycomb-associated geneASXL1in myelodysplastic syndromes and chronic myelomonocytic leukaemia
- (2009) Véronique Gelsi-Boyer et al. BRITISH JOURNAL OF HAEMATOLOGY
- Acquired mutations in TET2 are common in myelodysplastic syndromes
- (2009) Saskia M C Langemeijer et al. NATURE GENETICS
- A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q– syndrome
- (2009) Jillian L Barlow et al. NATURE MEDICINE
- Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype
- (2009) Daniel T Starczynowski et al. NATURE MEDICINE
- Mutation inTET2in Myeloid Cancers
- (2009) François Delhommeau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of RPS14 as a 5q- syndrome gene by RNA interference screen
- (2008) Benjamin L. Ebert et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now